Huvos AG - Search Results

1

Absence of a telomere maintenance mechanism as a favorable prognostic factor in patients with osteosarcoma.

Ulaner GA, Huang HY, Otero J, Zhao Z, Ben-Porat L, Satagopan JM, Gorlick R, Meyers P, Healey JH, Huvos AG, Hoffman AR, Ladanyi M. Ulaner GA, et al. Among authors: huvos ag. Cancer Res. 2003 Apr 15;63(8):1759-63. Cancer Res. 2003. PMID: 12702558

2

Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma.

Kubo T, Piperdi S, Rosenblum J, Antonescu CR, Chen W, Kim HS, Huvos AG, Sowers R, Meyers PA, Healey JH, Gorlick R. Kubo T, et al. Among authors: huvos ag. Cancer. 2008 May 15;112(10):2119-29. doi: 10.1002/cncr.23437. Cancer. 2008. PMID: 18338812 Free article.

3

Methylthioadenosine phosphorylase gene deletions are common in osteosarcoma.

García-Castellano JM, Villanueva A, Healey JH, Sowers R, Cordon-Cardo C, Huvos A, Bertino JR, Meyers P, Gorlick R. García-Castellano JM, et al. Clin Cancer Res. 2002 Mar;8(3):782-7. Clin Cancer Res. 2002. PMID: 11895909

4

mRNA expression levels of E2F transcription factors correlate with dihydrofolate reductase, reduced folate carrier, and thymidylate synthase mRNA expression in osteosarcoma.

Sowers R, Toguchida J, Qin J, Meyers PA, Healey JH, Huvos A, Banerjee D, Bertino JR, Gorlick R. Sowers R, et al. Mol Cancer Ther. 2003 Jun;2(6):535-41. Mol Cancer Ther. 2003. PMID: 12813132

5

Identification of prognostic markers in bone sarcomas using proton-decoupled phosphorus magnetic resonance spectroscopy.

Zakian KL, Shukla-Dave A, Meyers P, Gorlick R, Healey J, Thaler HT, Huvos AG, Panicek DM, Koutcher JA. Zakian KL, et al. Among authors: huvos ag. Cancer Res. 2003 Dec 15;63(24):9042-7. Cancer Res. 2003. PMID: 14695223

6

Expression of LDL receptor-related protein 5 (LRP5) as a novel marker for disease progression in high-grade osteosarcoma.

Hoang BH, Kubo T, Healey JH, Sowers R, Mazza B, Yang R, Huvos AG, Meyers PA, Gorlick R. Hoang BH, et al. Among authors: huvos ag. Int J Cancer. 2004 Mar;109(1):106-11. doi: 10.1002/ijc.11677. Int J Cancer. 2004. PMID: 14735475

7

Methotrexate levels and outcome in osteosarcoma.

Zelcer S, Kellick M, Wexler LH, Shi W, Sankaran M, Lo S, Healey J, Huvos AG, Meyers PA, Gorlick R. Zelcer S, et al. Among authors: huvos ag. Pediatr Blood Cancer. 2005 Jun 15;44(7):638-42. doi: 10.1002/pbc.20314. Pediatr Blood Cancer. 2005. PMID: 15704189

8

An expression signature classifies chemotherapy-resistant pediatric osteosarcoma.

Mintz MB, Sowers R, Brown KM, Hilmer SC, Mazza B, Huvos AG, Meyers PA, Lafleur B, McDonough WS, Henry MM, Ramsey KE, Antonescu CR, Chen W, Healey JH, Daluski A, Berens ME, Macdonald TJ, Gorlick R, Stephan DA. Mintz MB, et al. Among authors: huvos ag. Cancer Res. 2005 Mar 1;65(5):1748-54. doi: 10.1158/0008-5472.CAN-04-2463. Cancer Res. 2005. PMID: 15753370

9

Elevated physiologic tumor pressure promotes proliferation and chemosensitivity in human osteosarcoma.

Nathan SS, DiResta GR, Casas-Ganem JE, Hoang BH, Sowers R, Yang R, Huvos AG, Gorlick R, Healey JH. Nathan SS, et al. Among authors: huvos ag. Clin Cancer Res. 2005 Mar 15;11(6):2389-97. doi: 10.1158/1078-0432.CCR-04-2048. Clin Cancer Res. 2005. PMID: 15788690

10

Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma.

Laverdiere C, Hoang BH, Yang R, Sowers R, Qin J, Meyers PA, Huvos AG, Healey JH, Gorlick R. Laverdiere C, et al. Among authors: huvos ag. Clin Cancer Res. 2005 Apr 1;11(7):2561-7. doi: 10.1158/1078-0432.CCR-04-1089. Clin Cancer Res. 2005. PMID: 15814634

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

343 results

Search Page

Filters